BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li X, Pan XH, Fang Q, Liang Y. Pomolidomide for relapsed/refractory light chain amyloidosis after resistance to both bortezomib and daratumumab: A case report. World J Clin Cases 2022; 10(34): 12703-12710 [PMID: 36579116 DOI: 10.12998/wjcc.v10.i34.12703]
URL: https://www.wjgnet.com/2307-8960/full/v10/i34/12703.htm
Number Citing Articles
1
Bortezomib/daratumumabReactions Weekly 2023; 1969(1): 93 doi: 10.1007/s40278-023-44559-8